All articles

Photo by Pavel Danilyuk from Pexels

Novartis To Acquire Tourmaline Bio For $1.4B For Novel IL-6 Inhibitor Pacibekitug

Photo by Edward Jenner from Pexels

Rapport’s Positive Seizure Data With RAP-219 Could Lead To Phase 3 Program Initiation

Photo by Tima Miroshnichenko from Pexels

Arrowhead To Receive Up To $2 Billion As Part of Novartis Pact For siRNA ARO-SNCA

Photo by Pavel Danilyuk from Pexels

Cytokinetic’s Aficamten Push Bests SOC In Heart Muscle Disorder

Photo by Polina Tankilevitch from Pexels

Serina Establishes Registrational Study For SER-252 In PD Under Specific FDA Pathway

Photo by Tima Miroshnichenko from Pexels

Viking’s Stock Craters After Mid-Stage Obesity Trial Data With Oral Drug VK7235

Photo by Mikhail Nilov from Pexels

Precigen Scores FDA Approval Of Immunotherapeutic PAPZIMEOS For Rare Respiratory Disease

Photo by Martin Lopez from Pexels

One Patient Death Due To Kidney Injury In CytomX’s Ongoing Development Of CX-2051

Scroll to Top